Dr. Reddy's Laboratories Ltd. (500124.BY) said Monday a U.S. court has allowed the company to sell its generic version of Sanofi-Aventis's (SNY) anti-allergy drug, Allegra D-24.
The U.S. District Court of New Jersey on Jan. 28 lifted an earlier motion for preliminary injunction and cleared the sale of generic Allegra D-24, the Indian drug maker said in a statement.
Dr Reddy's had in March 2010 received the U.S. Food and Drug Administration's approval to make and sell generic Allegra D-24, but was restrained by the U.S. court from launching the product on the behest of Sanofi-Aventis and Albany Molecular Research.
via foxbusiness.com
No comments:
Post a Comment